Reply to Jorgensen, et al
- PMID: 32797235
- PMCID: PMC7454319
- DOI: 10.1093/cid/ciaa1212
Reply to Jorgensen, et al
Comment in
-
Response to Correspondence: Baricitinib: Impact on Coronavirus Disease 2019 (COVID-19) Coagulopathy? Jorgensen et al.Clin Infect Dis. 2021 Dec 6;73(11):e3980-e3981. doi: 10.1093/cid/ciaa1210. Clin Infect Dis. 2021. PMID: 32797226 Free PMC article. No abstract available.
Comment on
-
Use of Baricitinib in Patients With Moderate to Severe Coronavirus Disease 2019.Clin Infect Dis. 2021 Apr 8;72(7):1247-1250. doi: 10.1093/cid/ciaa879. Clin Infect Dis. 2021. PMID: 32597466 Free PMC article.
-
Baricitinib as Treatment for Coronavirus Disease 2019 (COVID-19): Friend or Foe of the Pancreas?Clin Infect Dis. 2021 Dec 6;73(11):e3977-e3978. doi: 10.1093/cid/ciaa1209. Clin Infect Dis. 2021. PMID: 32797239 Free PMC article. No abstract available.
References
-
- Nelp WB. Acute pancreatitis associated with steroid therapy. Arch Intern Med 1961; 108:702–10. - PubMed